Amgen, ImmunoGen, Oxford BioTherapeutics deal

Oxford received exclusive, worldwide rights to Xenomouse antibodies generated by Amgen and to ImmunoGen's TAP antibody-conjugate

Read the full 169 word article

How to gain access

Continue reading with a
two-week free trial.